000			02206 a2200553 4500
005			20250514050311.0
264		0	_c20021129
008			200211s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aHuang, Xiaojun
245	0	0	_aCombined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein. _h[electronic resource]
260			_bCancer research _cOct 2002
300			_a5727-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aAntigens, CD _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aB7-2 Antigen
650	0	4	_aCD4-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCD8-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCancer Vaccines _ximmunology
650	0	4	_aCombined Modality Therapy
650	0	4	_aFemale
650	0	4	_aImmunoglobulin G _xadministration & dosage
650	0	4	_aIndoles _xadministration & dosage
650	0	4	_aInterferon-gamma _xbiosynthesis
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aLymphocytes, Tumor-Infiltrating _xdrug effects
650	0	4	_aMammary Neoplasms, Experimental _xblood supply
650	0	4	_aMembrane Glycoproteins _xadministration & dosage
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aNeoplasm Metastasis
650	0	4	_aOxindoles
650	0	4	_aPropionates
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aPyrroles _xadministration & dosage
650	0	4	_aRecombinant Fusion Proteins _xadministration & dosage
650	0	4	_aSpleen _xdrug effects
700	1		_aWong, Michael K
700	1		_aYi, Huiming
700	1		_aWatkins, Simon
700	1		_aLaird, A Douglas
700	1		_aWolf, Stanley F
700	1		_aGorelik, Elieser
773	0		_tCancer research _gvol. 62 _gno. 20 _gp. 5727-35
999			_c12193781 _d12193781